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This study examined the accuracy of self-reported HIV-positive status as an indicator of 
entering HIV/AIDS treatment and determined the characteristics and correlates of 
receiving regular HIV/AIDS care among people who inject drugs (PWID). Data were 
collected through 1,412 personal interviews conducted in the cities of St. Petersburg, 
Russia and Kohtla-Järve, Estonia in 2012 and 2013. Overall, in both cities, 81.3% of 
PWID were accurately aware of their HIV-positive serostatus; in comparison to 
individual level correlates, structural and service utilization variables such as history of 
substance abuse treatment and history of incarceration were better determinants of 
accurate knowledge of HIV serostatus. We found that 32% of PWID in St. Petersburg 
and 73% of PWID in Kohtla-Järve who were aware of their HIV-positive serostatus had 
received regular HIV/AIDS care in the past year. Results of this study suggest that 
awareness of serostatus alone in this region does not necessarily translate into receiving 
HIV/AIDS care and that there is an urgent need for enhancing access to HIV/AIDS care 















Eastern Europe has experienced rapid growth in its HIV epidemic since the mid-
1990s. The HIV epidemic in this region has evolved from approximately 30,000 cases in 
1995, which were mostly transmitted through sexual intercourse, to an estimated 1.4 
million cases, with PWID accounting for the majority of cases [1]. The rapid increase in 
the incidence of HIV/AIDS in Eastern Europe over the past decade has been attributed to 
the social and political conditions in the region after the fall of the Soviet Union [2]. The 
opening of borders during the reforms of the early 1990s accompanied by increasing 
poverty, high unemployment, labor migration, poor health care, and the failure of 
political leaders to confront and mitigate these problems have led to the social conditions 
that have given rise to expanding injection drug use and ultimately the rapid spread of 
HIV [2, 3].  
The social and political environment after the dismantling of the Soviet Union and 
the region’s current drug use policies have resulted in an HIV epidemic that is 
concentrated among PWID with low levels of access to HIV/AIDS treatment and care.  
With over 40% of PWID in Eastern Europe being HIV positive and accounting for up to 
one-third of new HIV infections, the region is left with a large and growing number of 
injection drug users who are in immediate need of HIV/AIDS treatment and care [4-6].  
The extent of HIV treatment and care services varies greatly throughout the 
region. Although most of the former Soviet Union countries, with the assistance of 
international organizations, have taken steps to provide treatment and care services, the 
limited data available suggests that access to HIV/AIDS care among this marginalized 
population is low [7]. For instance, although access to HIV care and antiretroviral 
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treatment (ART) are theoretically universally available in the region, recent studies have 
shown that despite the high proportion of HIV cases among PWID, less than 15% of 
patients receiving highly active antiretroviral treatment (HAART) are current or former 
PWID [8]. Considering the low levels of access to ART, an examination of the steps in 
the HIV treatment cascade that occurs prior to the prescription of ART will help 
determine the barriers and facilitators of access to ART among this marginalized 
population.  
The first step in the HIV treatment cascade ensuring that HIV infected individuals 
receive an optimal treatment outcome is the test to determine whether they are infected 
followed by informing them of their HIV serortatus. Several studies have demonstrated 
that once people are aware of their HIV-positive status, they are less likely to participate 
in high-risk HIV transmission behaviors and will consequently have a lower risk of 
transmitting HIV [9]. In addition to reducing risky behavior and preventing further spread 
of infection, knowledge of HIV serostatus is essential for linking the patient to 
HIV/AIDS care and treatment [10].  Once an infected individual is aware of their HIV 
serostatus, it is important that they become connected with an HIV Health Care provider 
who is equipped to provide treatment. Failure to initiate timely HIV care after diagnoses 
is associated with greater likelihood of disease progression to AIDS and ongoing 
transmission of HIV to others [11]. After knowledge of serostatus, sustained engagement 
in HIV care is the next step to receiving successful HIV treatment.  
In this report, we examine the accuracy of self-reported HIV-positive status and 
access to HIV/AIDS care among PWID in St. Petersburg, Russia and Kohtla-Järve, 
Estonia. The Russian Federation and Estonia are two of only three countries in the region 
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with an estimated adult HIV prevalence exceeding 1% [8]. Although the region is 
beginning to see a shift from IDU to heterosexual HIV transmission, the HIV epidemic in 
St. Petersburg and Kohtla-Järve still remains concentrated among PWID which 
compromise 1.7% of the population in St. Petersburg and 3.5% of the population in 
Kohtla-Järve, for people between the ages of 14-55 [6, 12-15].  The estimated HIV 
prevalence among PWID in 2005 was reported to be 90% in Kohtla-Järve and 43% in St. 
Petersburg in 2007 [16, 17]. These staggering estimates of HIV prevalence among PWID 
in St. Petersburg and Kohtla-Järve are indicators of the large and growing number of 
people that are in immediate need of access to HIV/AIDS care.  
 Limited data are available on the rate of access to HIV/AIDS care in both cities. 
Therefore, the objective of this study was to assess the accuracy of self-reported HIV-
positive status, as an indicator of entering the HIV/AIDS treatment cascade and 
determining the characteristics and correlates of receiving regular HIV/AIDS care among 
PWID in the cities of Kohtla-Järve and St. Petersburg.  
 
II. Methods 
Study settings, Participants and Procedure 
Data for this study were collected through two anonymous cross-sectional studies 
of HIV and drug abuse epidemiology, access to prevention and treatment services, and 
social psychology research on minority and majority ethnic populations of PWID in 
Kohtla-Järve, Estonia and St. Petersburg, Russia. The study in Kohtla-Järve, Estonia was 
conducted between May and July of 2012 and recruited a total of 600 current PWID 
through the Me Aitame Sind (MAS) syringes exchange project facilities located in 
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Kohtla-Järve, Estonia. The study in St. Petersburg, Russia was conducted between 
January of 2012 and June of 2013 and recruited a total of 812 current PWID. 
Respondent-Driven Sampling (RDS) was used in both cities to recruit current 
PWID. Recruitment at both sites began with a non-random selection of “seeds” identified 
through venue-based sampling from substance abuse or HIV treatment programs. All 
eligible participants were provided with four coupons each to recruit other PWID into the 
study and recruitment continued until a predetermined sample size was achieved. 
Participants who completed the survey received a primary incentive, a food coupon 
equivalent to US$10.00, for participating in the study and a secondary incentive, a food 
coupon equivalent to US$5.00 for each recruited participant. 
Eligible participants had to be at least 18 years or older, spoke either Russian or 
Estonian (in Kohtla-Järve only), reported injection drug use in the last 4 weeks, and were 
able to provide informed consent. All participants IDU status was verified by checking 
their skin (arms and leg) for injection marks and/or they were asked to explain the 
process of preparing drugs for injection.  
 
Measures 
Study participants at both sites completed a similar questionnaire administered in 
a private setting by trained staff in either Estonian or Russian languages. Data collected 
for the interview included demographic and socioeconomic characteristic; IDU network 
and recruitment information; contact with drug treatment services and prison; history of 
alcohol, tobacco and drug use; HIV risk practices associated with injecting drugs; sexual 
behavior, sexual partnerships, history of sex work; knowledge of HIV/AIDS and TB; 
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previous HIV testing, reported HIV antibody status and history antiviral treatment; use of 
treatment, HIV prevention, social welfare and harm reduction.  Participants were also 
asked to provide a blood sample for serological testing. 
 Participants’ self-reported HIV status was obtained.  History of HIV care and 
treatment was only measured among PWID who self-reported being HIV positive. 
Access to HIV care was determined by whether the participant had visited an “HIV 
doctor” at least once in the past 12 months. Current and previous use of ART was also 
only measured among participants who self-reported HIV positive.    
 The interview was conducted in approximately 40-60 minutes. After the 
interview, all participants were offered pre-test HIV counseling, testing, and appropriate 
medical and social service referrals. During the follow-up meeting, each participant was 
informed of the results of their HIV test and received post HIV testing counseling. 
 
HIV antibody testing 
 
In Kohtla-Jarve, whole venous blood specimens were collected from all 
participants by a trained phlebotomist to detect antibodies to HIV (anti-HIV). Specimens 
were screened using commercially available test kits ADVIA Centaur(®) HIV Ag/Ab 
Combo assay (Siemens), which have specificities and sensitivities in exccess of 99.5%.  
At the post-testing counseling, the participants were provided with information on where 
they could receive official testing. The testing was conducted at the Quattromed HTI 








For the purpose of this study, PWID who tested HIV-positive by serology 
completed as part of the study were categorized into two groups based on their self-
reported HIV status. One category included PWID who self-reported HIV-positive and 
tested HIV-positive by the serology test. The other group included PWID who self-
reported HIV-negative but tested HIV-positive. Those who self-reported HIV negative 
include respondents who had never been tested for HIV prior to this study and those who 
had been tested but reported not knowing their HIV status (“Inconclusive”, “Did not get 
the result”, “don’t know”, and “No answer”). 
The sample was described based on their demographic, incarceration history, drug 
use behavior, self-reported duration of HIV infection, self-reported latest CD4 count, and 
service utilization variables using standard descriptive statistics.  
The following correlates were examined to identify factors associated with 
accurate knowledge of self-reported HIV-positive serostatus: Demographic; History of 
incarceration; Injecting drug use behavior; and access to substance abuse treatment 
services. The indicators for injection drug use included the number of years that the 
respondent had been injecting drugs and the number of days the respondent reported 
injecting drugs, at a minimum, at least once in the past thirty days. The history of 
injection drug use was calculated by subtracting the respondent’s age at the time the 
study from the age they reported to have injected drugs for the first time for non-medical 
purposes. To estimate correlates of accurate knowledge of self-reported HIV-positive 
serostatus, logistic regression models and bivariate measure of association were used.  
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In addition, among respondents who tested HIV-positive and self-reported HIV-
positive, drug use risk behaviors, incarceration history, duration of self-reported HIV 
infection, and knowledge of where to receive HIV treatment were assessed for their 
relationship with visiting an “HIV doctor” at least once in the past 12 months. To 
estimate correlates of accessing HIV care, bivariate and multivariate logistic regression 
models were used. Covariates that were associated with the outcome of interest using the 
critical value of P<0.2 were included in the initial multivariate model. The final model 
was selected using a manual backward elimination procedure, which eliminated all 
covariates that did not remain significant at the critical value of P<0.05. 
All continuous variables were dichotomized based on a priori meaningful cut 




A total of 1,412 active PWID were recruited into the study: 812 PWID were 
recruited in St. Petersburg and 600 PWID were recruited in Kohtla-Järve. Among the 600 
respondents in Kohtla-Järve, a total of 22 participants self-reported HIV positive, but 
tested HIV negative during the study. Of the 22 respondents, a total of 12 were excluded 
from the study and the remaining 10 were kept in the analysis. The participants excluded 
from the analysis had not only reported being HIV+ but also reported receiving HIV care. 
The 10 participants that were retained in the study only reported being HIV+ but did not 
report being in care. This may be attributed to error in data entry. 
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Participant characteristics  
Of the 812 injecting drug users recruited in St. Petersburg, a total of 452 (55.7%) 
of the participants tested HIV positive by serology at the study visit and are described in 
Table 1. Among those retained for analysis (N=452), the majority were Russian (94.5%) 
males (79.6%) with an average age of 33.1 years (SD 4.2) who had never married 
(51.1%). The majority had completed 9-12 years of education (82.3%).  Three-fourths 
(75.7%) of the respondents reported having difficulty getting by on their income but only 
eight PWID had been homeless in the past six months. The mean duration of injection 
drug use was 14.4 years (SD 4.6) and 95.3% reported to have injected drugs every day in 
the past thirty days (mean=20.9, SD=7.8). Thirty nine percent reported to have ever been 
incarcerated. 
Based on the respondents’ self-reported first positive HIV test, 379/452 (83.3%) 
of PWID had been aware of their HIV diagnosis for an average of 6.2 years (SD 3.4). The 
mean self-reported CD4 count was 346.7 cells/mm
3
 (SD 239 cells/mm
3
). The vast 
majority of PWID (78.3%) were covered by Russian health insurance. The following is a 
list of health care services utilized by this sample: 32.4% had visited a physician for 
HIV/AIDS care at least once in the past 12 months; 48.8% had received ART and among 
those who had received ART, 74.6% were receiving ART at the time the study was 
conducted; 78.8% of the respondents reported to have received substance abuse treatment 
and only eleven of those PWID (3.1%) were receiving treatment when recruited into the 
study.   
Of the total 589 PWID in Kohtla-Järve who were retained in the analysis, 370 
(62.8%) tested HIV-positive by serology at the study visit and are described in Table 1. 
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This group was predominantly males (73.4%) with a mean age of 30.4 years (SD 4.5). 
Approximately half of the respondents had never been married (51.9%) and had 
completed less than 9 years of education (50.5%). The vast majority were of Russian 
decent (80%) and only 39 (10.6%) of the PWID were of Estonian descent. Ninety-one 
percent reported to have a difficult time coping with their income and only 23 (6.2%) had 
been homeless in the past six months. Fifty-nine percent of PWID self-reported history of 
injection drug use exceeded eleven years (mean=12.2 years, SD=4.7) and 57.7% reported 
to have not injected every day in the past 30 days (mean=16.2 days, SD=9.3). Majority of 
respondents (63.2%) reported a history of incarceration. 
Among the 370 HIV-positive PWID, the self-reported duration of HIV infection 
was calculated from the 290 PWID who self-reported an HIV-positive test result. The 
mean duration of self-reported HIV-infection was 7.4 years (SD 3.6) and 55.5% reported 





). The following is a list of health care services 
utilized by this sample: 73.1% had visited a physician for HIV/AIDS care at least once in 
the past 12 months; 82.8% had received ART and among those who had received 
treatment, 86.5% were receiving ART at the time the study was conducted; 60.8% of the 
respondents reported to have received substance abuse treatment and of those PWID 
36.7% were receiving treatment during the course of the study. 
Overall, the samples in both cities were similar in terms of age, sex, marital status, 
ethnicity, financial status and access to state-provided health insurance. In comparison to 
Kohtla-Järve, a greater proportion of the sample in St. Petersburg had completed more 
than nine years of education and the history of incarceration was 40% lower. A greater 
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proportion in Kohtla-Järve tested HIV-positive by serology at the study visit (63% vs. 
56%). Although the mean duration of self-reported HIV infection in St. Petersburg was 
shorter, the respondents reported a higher level of injecting risk behavior in comparison 
to Kohtla-Järve. The mean number of years of injection drug use in St. Petersburg was 
2.2 years greater and three-quarters of the sample in St. Petersburg reported a history of 
injection drug use that exceeded eleven years. Also, the frequency of injection drug use in 
the past thirty days on average in St. Petersburg was 25% greater than in Kohtla-Järve.  
Access to HIV/AIDS related healthcare was higher in Kohtla-Järve. The 
proportion of HIV-positive PWID who reported visiting a physician for HIV/AIDS care 
was 2.5 times higher in Kohtla-Järve. The proportion of HIV-positive respondents who 
reported ever having taken ART was approximately 30% higher in Kohtla-Järve. The 
majority of respondents in both cities reported to have received access to substance abuse 
treatment services in the past. 
 
Knowledge of HIV-positive status 
 Among the 812 respondents in St. Petersburg, 760 (93.6%) reported to have been 
tested for HIV prior to enrollment in the present study.  Of those who had been tested, 
383/760 (50.4%) self-reported being HIV positive, 366/760 (48.2%) reported that they 
were HIV-negative, and 14/760 (1.8%) didn’t know their status. Ninety percent (531/589) 
of the respondents in Kohtla-Järve reported ever having been tested for HIV prior to this 
study. Fifty-six percent (299/531) of those who had been tested previously reported to be 
HIV positive, 43% (228/531) reported that they were HIV-negative, and 11.5% (61/531) 
reported not knowing their HIV status.  
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Accuracy of knowledge of HIV-positive serostatus is presented in Figure 1. 
Among the 383 PWID in St. Petersburg who self-reported positive serostatus, 100% were 
HIV positive by serology test. Of the 427 who self-reported HIV-negative, 69 (16%) 
tested HIV-positive and 358 (84%) accurately reported their HIV-negative status.  In 
Kohtla-Järve, among the 299 who self-reported positive serostatus, 289(97%) were HIV-
positive by serology test. Of the 228 who self-reported HIV-negative, 81 (36%) tested 
HIV-positive by the serology test and 208 (91%) accurately reported their HIV-negative 
status. Overall, a higher proportion (85% vs. 78%) of respondent in St. Petersburg had 
accurate knowledge of their HIV-positive status.  
 
Correlates of accurate knowledge of HIV status 
As indicated in Table 2, correlates of accurately reporting HIV-positive status 
were measured using bivariate analysis. In St. Petersburg, among the 452 respondents 
with HIV-positive serostatus, in the unadjusted analysis, Russian ethnicity (OR 4.16, 
95% CI 1.78-9.69), history of IDU exceeding eleven years (OR 2.66, 95% CI 1.56-4.55), 
history of receiving substance abuse treatment (OR 2.70, 95% CI 1.56-4.69), and 
financial hardship (OR 1.85, 95% CI 1.07-3.21) were associated with accurate knowledge 
of HIV-positive status. Among the 370 PWID in Kohtla-Järve who tested HIV-positive 
by serology test, in the unadjusted analysis, age exceeding 30 years (OR 1.88, 95% CI 
1.13-3.13), history of incarceration (OR 4.38, 95% CI 2.60-7.36), IDU history exceeding 
eleven years (OR 2.16, 95% CI 1.31-3.55), financial hardship (OR 2.20, 95% CI 1.03-
4.68), and history of receiving substance abuse treatment (OR 4.35, 95% CI 2.58-7.35) 
were all associated with accurate knowledge of the respondents HIV-status.  
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As indicated in Table 2 (far right column), in the adjusted analysis of the St. 
Petersburg study, Russian ethnicity (OR 3.95, 95% CI 1.62-9.66), history of IDU 
exceeding eleven years (OR 2.50, 95% CI 1.44-4.36), and ever receiving substance abuse 
treatment (OR 2.54, 95% CI 1.43-4.50) remained significantly associated with accurate 
knowledge of self-reported HIV-positive status. In the adjusted analysis of the Kohtla-
Järve study, history of incarceration (OR 3.28, 95% CI 1.90-5.66) and having ever 
received substance abuse treatment (OR 3.20, 95% CI 1.44-5.53) remained significantly 
associated with the outcome of interest.  
 
Correlates of visiting a physician for HIV/AIDS care 
 Correlates of visiting a physician for HIV/AIDS care at least once in the past 12 
months among PWID in St. Petersburg who tested HIV positive and self-reported HIV-
positive is described in Table 3. Among the 383 PWID who were analyzed for the 
outcome of interest, in the unadjusted analysis, completing over 12 years of education 
(OR 2.92, 95% CI 1.03-8.27), having health insurance (OR 1.84, 95% CI 1.03-3.26), 
financial hardship (OR 0.52, 95% CI 0.32-0.86), duration of HIV infection exceeding 
eight years (OR 2.40, 95% CI 1.46-3.92), knowledge of where to receive HIV treatment 
(OR 1.93, 95% CI 0.21-17.44) were all significantly correlated with receiving HIV/AIDS 
care.  
Among the PWID in Kohtla-Järve who tested HIV-positive and self-reported 
HIV-positive, the following correlates were all significantly correlated with the outcome 
of interest: Male (OR 0.46, 95% CI 1.46-3.92), Russian ethnicity (OR 1.92, 95% CI 1.01-
3.61), having health insurance (OR 8.62, 95% CI 4.31-17.25), HIV infection that 
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exceeded eight years (OR 2.37, 95% CI 1.36-4.13), and knowledge of where to receive 
HIV care (OR 8.71, 95% CI 1.72-44.10). 
In the adjusted analysis, at both sites, having state-issued health insurance (St. 
Petersburg: OR 1.93, 95% CI 1.06-3.50, Kohtla-Järve: OR 8.92, 95% CI 4.21-18.9) and 
HIV infection exceeding eight years (St. Petersburg: OR 2.49, 95% CI 1.51-4.13, Kohtla-
Järve: OR 2.19, 95% CI 1.18-4.07) remained significantly associated with visiting an 
“HIV doctor” at least once in the past 12 months. In St. Petersburg alone, in the adjusted 
analysis, financial hardship (OR 0.47, 95% CI 0.28-0.80) also remained significantly 
correlated with receiving HIV/AIDS care. In Kohtla-Järve, in addition to the 
aforementioned covariates, sex (OR 0.33, 95% CI 0.15-0.73) and knowledge of where to 
receive HIV care (OR 2.0, 95% CI 1.30-42.6) remained statistically significant. 
 
IV. Discussion 
Our findings suggest that the majority of the PWID sample population in St. 
Petersburg (94%) and Kohtla-Järve (90%) had been tested for HIV prior to this study. An 
examination of the accuracy of the participant’s self-reported HIV- positive serostatus 
revealed that a higher proportion of respondents in St. Petersburg (85% vs. 78%) had 
accurate knowledge of their HIV-positive status. However, we found that only a small 
proportion (32%) of HIV-positive PWID aware of their serostatus had received 
HIV/AIDS care in St. Petersburg. In order to better understand the differences in 
HIV/AIDS care and treatment among the PWID population in St. Petersburg and Kohtla-
Järve, we examined various individual and structural level correlates of accurate 
knowledge of HIV status and access to HIV/AIDS care. 
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Our analysis of individual and structural-level correlates of accurate knowledge of 
HIV-positive serostatus revealed several significant relationships. Of the individual level 
correlates we analyzed, in St. Petersburg, Russian ethnicity and history of injection drug 
use exceeding eleven years were associated with greater likelihood of having accurate 
knowledge of HIV-positive serostatus. Among the structural-level variables, in both 
cities, history of receiving substance abuse treatment and in Kohtla-Järve, history of 
incarceration were associated with greater likelihood of accurate knowledge of HIV-
positive serostatus. The aforementioned covariates – incarceration and entering substance 
abuse treatment - that we found to be statistically significant are all events that provide 
contact with settings that require HIV testing. Therefore, it is possible that, in comparison 
to individual-level correlates, structural and service utilization variables are better 
determinants of accurate knowledge of HIV status. These findings also suggest that 
policies aimed at increasing the rate of HIV testing in prison settings and through harm 
reduction services are reaching many more in this marginalized population. 
Our findings suggest that awareness of serostatus alone does not necessarily 
translate into receiving HIV/AIDS care. We found that 32% of PWID in St. Petersburg 
and 73% of PWID’s in Kohtla-Järve who were aware of their HIV-positive serostatus had 
visited an “HIV doctor” at least once in the past 12 months. Several important individual 
and structural-level factors emerged in our analysis as correlates of access to HIV/AIDS 
care. First, in both cities, PWID aware of their HIV-positive serostatus, who had state-
issued health insurance, and self-reported to had been infected with HIV for greater than 
eight years were significantly more likely to be receiving HIV/AIDS care. This finding 
suggests that in both cities PWID who had been recently infected and were aware of their 
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HIV-positive status were not receiving HIV/AIDS treatment and care. Several other 
studies have reported similar findings on PWID receiving treatment and care later in the 
course of HIV infection and often after the disease has progressed to AIDS [5, 18]. There 
are several plausible explanations for the late presentation of PWID for HIV/AIDS 
treatment and care. For instance, any of the following “socio-political” barriers: social 
marginalization; risk of criminal sanctions; incarceration; or financial barrier may have 
played a role in the lack of access to treatment and care among this marginalized 
population [5, 19, 20]. Our findings revealed that PWID in St. Petersburg who reported 
experiencing financial difficulties were less likely to have visited an “HIV doctor” in the 
past 12 months. An additional explanation for the lack of access to treatment might be 
explained by the lack of post HIV-testing counseling and/or the lack of referrals to 
HIV/AIDS treatment and care providers. Further research is needed to fully understand 
the barriers to HIV/AIDS care among this marginalized population in St. Petersburg and 
Kohtla-Järve. 
This study has several limitations that need to be addressed.  First, our findings 
may be affected by the limitations that apply to using self-reported measures of drug 
abuse behaviors and HIV testing histories. Participants might tend to avoid reporting 
what they perceive interviewers will judge as socially improper responses on sensitive 
issues, such as drug abuse behaviors, and provide responses that are more socially 
desirable [21] . Also, the participants’ duration of HIV infection was calculated from 
their self-reported HIV testing history and therefor might be subject to unintentional 
inaccurate reporting due to recall bias [10]. Despite these potential limitations, these 
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results present the first measurement of access to HIV/AIDS care and treatment among 
PWID in St. Petersburg, Russia and Kohtla-Järve, Estonia.  
The findings of this study have significant policy implications, suggesting an 
urgent need for enhancing access to HIV/AIDS care and treatment among this 
marginalized population. Our data revealed sub-optimal coverage of HIV/AIDS care 
especially among the recently infected IDU population in St. Petersburg, Russia. Further 
research is needed to investigate the lack of utilization of HIV/AIDS care, in both cities, 
especially among those who have been recently been infected with HIV.  
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Table 1 - Characteristics of PWID who tested HIV-positive   




Age (years), mean ± SD 33.1±4.2 30.4±4.5 
Sex   
Male 360/452(79.6) 271/369(73.4) 
Female 92/452(20.3) 98/369 (26.5) 
Education   
≤ 9 yrs 40/452(8.8) 187/370(50.5) 
9-12 yrs 372/452(82.3) 183/370 (49.5) 
>12 yrs 40/452(8.8) 0(0) 
Marital status   
Married/common law 135/452(29.9) 145/370 (39.2) 
Widowed 2/452(0.4) 7/370 (1.9) 
Divorced 84/452(18.6) 26/370 (7.0) 
Never Married 231/452(51.1) 192/370 (51.9) 
Ethnicity   
Russian 427/452(94.5) 299/369 (80.0) 
Estonian 0/452(0) 39/369 (10.6) 
Other 25/452(5.5) 31/369 (8.4) 
Health insurance   
Yes 354/452(78.3) 306/370 (82.7) 
No 97/452(21.5) 64/370 (17.3) 
Currently coping with income   
Yes 109/449(24.3) 33/367(9.0) 
No 340/449(75.7) 334/367 (91.0) 
Homeless in the past 6 months   
Yes 8/452(1.8) 23/370 (6.2) 
No 444/452(98.2) 347/370 (93.8) 
Ever been in prison or jail   
Yes 176/452(38.9) 234/370 (63.2) 
No 276/452(61.1) 136/370 (36.8) 
History of Injection drug use   
≤11 yrs 111/452(24.6) 151/370 (40.8) 
>11 yrs 341/452(75.4) 219/370 (59.2) 
 Mean=14.4, SD=4.6 Mean=12.2, SD=4.7 
Frequency of IDU in past 30 days   
<30 days 21/452(4.6) 346/369 (93.8) 
≤30 days 431/452(95.3) 24/369 (6.5) 
 Mean=20.9, SD=7.8 Mean=16.2, SD=9.3 
Ever received substance abuse treatment   
Yes 356/452 (78.8) 225/370 (60.8) 
No 96/452 (21.2) 145/370 (39.2) 
Currently receiving substance abuse treatment   
Yes 11/356(3.1) 83/226(36.7) 
No 345/356(96.9) 143/226(63.3) 
Received HIV care at least once in the past 12 months   
Yes 125/386 (32.4) 212/290(73.1) 
No 261/386 (67.6) 78/290(2.7) 
Duration of HIV infection   
≤ 8 yrs 290/379(76.5) 161/290(55.5) 
>8 yrs 89/379(23.5) 129/290(44.5) 
 Mean=6.2, SD=3.4 Mean=7.4, SD=3.6 
Latest CD4 count (cells/mm3)   
<350 75/207(36.2) 74/154(48.0) 
≥350 132/207(63.8) 80/154(51.9) 
 Mean=346.7,SD=239.1 Mean=387.7, SD=245.3 
Ever taken any antiretroviral therapy   
Yes 63/129(48.8) 139/169(82.2) 
No 66/129(51.2) 29/169 (17.2) 
Currently receiving antiretroviral therapy   
Yes 47/63(74.6) 122/141(86.5) 
No 16/63(25.4) 19/141(13.5) 
* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding. 




Table 2 - Correlates of self-reported HIV-positive status among PWID in St. Petersburg who tested HIV+ 
Characteristic                                 HIV+ Serostatus (n=452)                    
               SR- (n=69)          SR+ (n=383)                uOR           95% CI                  aOR                      95% CI    
 



















Age (years)         
≤30 25(36.2) 110(28.7) Referent (0.82-2.42)     
>30 44(63.8) 273(71.3) 1.41      
Sex         
Male 58(84.1) 302(78.8) 0.71 (0.35-1.41)     
Female 11(15.9) 81(21.1) Referent      
Education         
≤ 9 yrs 4(5.8) 36(92.3) Referent      
9-12 yrs 58(84.1) 314(82.0) 0.60 (0.21-1.75)     
>12 yrs 7(10.1) 33(8.6) 0.52 (0.14-1.95)     
Marital status         
Married/common law 19(27.5) 116(30.3) 0.71 (0.31-1.66)     
Divorced or widowed 9(12.8) 77(20.1) Referent      
Never married 41(59.4) 190(49.6) 0.54 (0.25-1.17)     
Ethnicity         
Russian 59(85.5) 368(96.1) 4.16 (1.78-9.69) 3.95 (1.62-9.66)   
Other 10(14.5) 15(3.9) Referent  Referent    
Health insurance         
Yes 52(75.4) 302(78.8) 1.23 (0.68-2.25)     
No 17(24.6) 80(20.1) Referent      
Currently coping with income         
Yes 24(34.8) 85(22.4) Referent      
No 45(65.2) 295(77.6) 1.85 (1.07-3.21)     
Ever been in prison or jail         
Yes 20(29.0) 156(40.7) 1.68 (0.96-2.94)     
No 49(71.0) 227(59.3) Referent      
History of Injection drug use         
≤11 yrs 29(42.0) 82(21.4) Referent  Referent    
>11 yrs 40(58.0) 301(78.6) 2.66 (1.56-4.55) 2.50 (1.44-4.36)   
Frequency of IDUPWID in past 
30 days 
      
  
<30 days 4(5.8) 17(4.4) 1.32 (0.43-4.06)     
≥30 days 65(94.2) 366(95.6) Referent      
Ever received substance abuse 
treatment 
      
  
Yes 43(62.3) 313(81.7) 2.70 (1.56-4.69) 2.54 (1.43-4.50)   
No 26(37.7) 70(18.3) Referent  Referent   
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Table 2 - Correlates of self-reported HIV-positive status among PWID in Kohtla-Järve who tested HIV+ 
Characteristic                                 HIV+ Serostatus (n=370)                   



















Age (years)          
≤30 52(64.2) 141(48.8) Referent       
>30 29(35.8) 148(51.2) 1.88 (1.13-3.13)      
Sex          
Male 60(74.1) 211(73.3) 0.96 (0.55-1.68)      
Female 21(25.9) 77(26.7) Referent       
Education          
≤ 9 yrs 38(46.9) 149(51.6) Referent (0.51-1.36)      
9-12 yrs 43(53.1) 140(48.4) 0.83       
>12 yrs 0(0) 0(0)        
Marital status          
Married/common law 41(50.6) 104(36.0) 0.60 (0.20-1.81)      
Divorced or widowed 4(4.9) 29(10.0) Referent       
Never married 36(44.4) 156(54.0) 0.35 (0.12-1.06)      
Ethnicity          
Russian 63(77.8) 236(81.9) 1.30 (0.71-2.37)      
Other      18(22.2) 52(18.1) Referent       
Health insurance          
Yes 63(77.8) 243(84.1) 1.51        (0.82-2.78)      
No 18(22.2) 46(15.9)        Referent       
Currently coping with income          
Yes 12(14.8) 21(7.3) Referent       
No 69(85.2) 265(92.7) 2.20 (1.03-4.68)      
Ever been in prison or jail          
Yes 29(35.8) 205(70.9) 4.38 (2.60-7.36) 3.28 (1.90-5.66)    
No 52(64.2) 84(29.1) Referent  Referent     
History of Injection drug use          
≤11 yrs 45(55.6) 106(36.7) Referent       
>11 yrs 36(44.4) 183(63.3) 2.16 (1.31-3.55)      
Frequency of IDU in past 30 days          
<30 days 0(0) 265(91.7)        
≥30 days 81(100.0) 24(8.3)        
Ever received substance abuse 
treatment 
    
     
Yes 27(33.3) 198(68.5) 4.35 (2.58-7.35) 3.20 (1.84-5.53)    
No 54(66.7) 91(31.5) Referent  Referent     
* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding. 
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Table 3 - Correlates of receiving HIV care at least once every 12 months among PWID who self-reported HIV positive and 
serotested HIV-positive   
Characteristic                           St. Petersburg (N=383)                      













Age (years)          
≤30 76(29.3) 34(27.4) Referent       
>30 183(70.7) 90(72.6) 1.10 (0.68-1.77)      
Sex          
Male 209(80.7) 93(75.0) 0.72       
Female 50(19.3) 31(25.0) Referent (0.43-1.20)      
Education          
≤ 9 yrs 28(10.8) 8(6.4) Referent       
9-12 yrs 213(82.2) 101(81.4) 1.66 (0.73-3.77)      
>12 yrs 18(6.9) 15(12.1) 2.92 (1.03-8.27)      
Marital status          
Married/common law 83(32.0) 33(26.6) 0.88 (0.47-1.65)      
Divorced or widowed 53(20.5) 24(19.3) Referent       
Never married 123(47.5) 67(54.0) 1.20 (0.68-2.12)      
Ethnicity          
Russian 249(96.1) 119(96.0) 0.96 (0.32-2.86)      
Other 10(3.9) 5(4.0) Referent       
Health insurance          
Yes 197(76.1) 105(84.7) 1.84 (1.03-3.26) 1.93 (1.06-3.50)    
No 62(23.9) 18(14.5) Referent  Referent     
Currently coping with income          
Yes 48(18.6) 37(30.3) Referent  Referent (0.28-0.80)    
No 210(81.4) 85(69.7) 0.52 (0.32-0.86) 0.47     
Ever been in prison or jail          
Yes 107(41.3) 49(39.5) 0.93 (0.60-1.44)      
No 152(58.6) 75(60.5) Referent       
History of Injection drug use          
≤11 yrs 60(23.2) 22(17.7) Referent       
>11 yrs 199(76.8) 102(82.3) 1.40 (0.81-2.41)      
Frequency of IDU in past 30 days          
<30 days 62(23.9) 45(36.3) 1.16       
≥30 days 197(76.1) 79(63.7) Referent (0.40-3.36)      
Ever received substance abuse 
treatment 
      
   
Yes 212(81.8) 23(18.5) 0.97 (0.56-1.69)      
No 47(18.1) 101(81.4) Referent       
Duration of HIV disease          
≤8 yrs 208(82.2) 81(65.9) Referent  Referent     
>8 yrs 45(17.8) 42(34.1) 2.40 (1.46-3.92) 2.49 (1.51-4.13)    
Do you know where you can 
get HIV treatment 
      
   
No 4(1.6) 1(0.8) Referent       
Yes 255(98.5) 123(99.2) 1.93 (0.21-17.44)      
* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding. 
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Table 3 - Correlates of receiving HIV care at least once every 12 months among PWID who self-reported HIV positive and 
serotested HIV-positive   
Characteristic                                      Kohtla-Järve (N=289)                      







Age (years)          
≤30 39(50.0) 102(48.3) Referent       
>30 39(50.0) 109(51.7) 1.07 (0.63-1.80)      
Sex          
Male 65(83.3) 146(69.5) 0.46 (0.23-0.89) 0.33 (0.15-0.73)    
Female 13(16.7) 64(30.5) Referent  Referent     
Education          
≤ 9 yrs 42(53.8) 107(50.7) 1.13 (0.67-1.91)      
9-12 yrs 36(25.7) 104(49.3) Referent       
>12 yrs 0(0.0) 0(0.0)        
Marital status          
Married/common law 24(30.8) 80(37.9) 1.75 (0.72-4.28)      
Divorced or widowed 10(12.8) 19(9.0) Referent       
Never married 44(56.4) 112(53.1) 1.34 (0.58-3.12)      
Ethnicity          
Russian 58(74.4) 178(84.8) 1.92 (1.02-3.61)      
Other 20(25.6) 32(15.2) Referent       
Health insurance          
Yes 47(60.3) 196(92.9) 8.62 (4.31-17.25) 8.92 (4.21-18.9)    
No 31(39.7) 15(7.1) Referent  Referent     
Currently coping with income          
Yes 5(6.5) 16(92.3) Referent       
No 72(93.5) 193(92.3) 0.84 (0.30-2.37)      
Ever been in prison or jail          
Yes 59(75.6) 146(69.2) 0.72 (0.40-1.31)      
No 19(24.4) 65(30.8) Referent       
History of Injection drug use          
≤11 yrs 31(39.7) 75(35.5) Referent       
>11 yrs 47(60.3) 136(64.4) 1.20 (0.70-2.04)      
Frequency of IDU in past 30 
days 
      
   
<30 days 71(91.0) 194(91.9) Referent       
≥30 days 7(9.0) 17(8.1) 0.89 (0.35-2.23)      
Ever received substance abuse 
treatment 
      
   
Yes 25(32.0) 66(31.3) 1.04 (0.59-1.81)      
No 53(67.9) 145(68.7) Referent       
Duration of HIV infection          
≤8 yrs 55(70.5) 106(50.2) Referent     Referent     
>8 yrs 23(29.5) 105(49.8) 2.37 (1.36-4.13) 2.19 (1.18-4.07)    
Do you know where you can 
get HIV treatment 
      
   
Yes 72(92.3) 209(99.0) 8.71 (1.72-44.10) 2.0 (1.30-42.6)    
No 6(7.7) 2(0.9) Referent  Referent     
* Numbers may not sum to total due to missing data, and percentages may not sum to 100% due to rounding. 
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